Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Inovio Pharmaceuticals Net Income 2006-2019 | INO

Inovio Pharmaceuticals net income from 2006 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  
Inovio Pharmaceuticals Annual Net Income
(Millions of US $)
2018 $-97
2017 $-88
2016 $-74
2015 $-29
2014 $-36
2013 $-66
2012 $-20
2011 $-15
2010 $-18
2009 $-24
2008 $-13
2007 $-11
2006 $-14
2005 $-26
Inovio Pharmaceuticals Quarterly Net Income
(Millions of US $)
Q3 2019 $-23
Q2 2019 $-29
Q1 2019 $-29
Q4 2018 $-33
Q3 2018 $-25
Q2 2018 $-7
Q1 2018 $-32
Q4 2017 $-22
Q3 2017 $-34
Q2 2017 $-9
Q1 2017 $-23
Q4 2016 $-26
Q3 2016 $-21
Q2 2016 $-19
Q1 2016 $-8
Q4 2015 $-18
Q3 2015 $6
Q2 2015 $-6
Q1 2015 $-11
Q4 2014 $-7
Q3 2014 $-7
Q2 2014 $-11
Q1 2014 $-11
Q4 2013 $-15
Q3 2013 $-31
Q2 2013 $-11
Q1 2013 $-9
Q4 2012 $-1
Q3 2012 $-7
Q2 2012 $-4
Q1 2012 $-8
Q4 2011 $-5
Q3 2011 $-5
Q2 2011 $-3
Q1 2011 $-2
Q4 2010 $-6
Q3 2010 $-1
Q2 2010 $-8
Q1 2010 $-2
Q4 2009 $-7
Q3 2009 $-3
Q2 2009 $-11
Q1 2009 $-3
Q4 2008 $-4
Q3 2008 $-2
Q2 2008 $-4
Q1 2008 $-3
Q4 2007 $-1
Q3 2007 $-3
Q2 2007 $-4
Q1 2007 $-4
Q4 2006 $-8
Q3 2006 $-3
Q2 2006 $-3
Q1 2006
Q4 2005 $-12
Q3 2005 $-3
Q2 2005 $-2
Q1 2005 $-9
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.384B $0.030B
Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. Inovio's clinical programs include human papillomavirus (HPV)/cervical cancer (therapeutic), avian influenza (preventative), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) vaccines. It is advancing preclinical research for a universal seasonal/pandemic influenza vaccine. The Company's partners and collaborators include University of Pennsylvania, National Microbiology Laboratory of the Public Health Agency of Canada, NIAID, Merck, ChronTech, University of Southampton, and HIV Vaccines Trial Network. Inovio Pharmaceuticals, Inc. is headquartered in Blue Bell, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $139.657B 16.09
CSL (CSLLY) Australia $95.348B 0.00
Gilead Sciences (GILD) United States $80.893B 10.02
Vertex Pharmaceuticals (VRTX) United States $60.150B 61.39
Biogen (BIIB) United States $51.283B 8.80
Illumina (ILMN) United States $48.069B 52.74
Regeneron Pharmaceuticals (REGN) United States $39.153B 17.14
Alexion Pharmaceuticals (ALXN) United States $24.021B 11.86
Seattle Genetics (SGEN) United States $19.769B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.134B 0.00
Incyte (INCY) United States $16.853B 39.12
BioMarin Pharmaceutical (BMRN) United States $15.381B 0.00
Genmab (GNMSF) Denmark $14.047B 62.04
Alnylam Pharmaceuticals (ALNY) United States $13.151B 0.00
Galapagos (GLPG) Belgium $12.724B 32.78
Exact Sciences (EXAS) United States $11.968B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.238B 53.94
BeiGene (BGNE) Cayman Islands $10.324B 0.00
Sarepta Therapeutics (SRPT) United States $8.474B 0.00
Bio-Techne Corp (TECH) United States $8.337B 55.81
BioNTech SE (BNTX) Germany $8.304B 0.00
QIAGEN (QGEN) Netherlands $7.852B 25.60
Guardant Health (GH) United States $7.655B 0.00
Amarin (AMRN) Ireland $7.416B 0.00
Moderna (MRNA) United States $7.155B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.951B 17.67
ACADIA Pharmaceuticals (ACAD) United States $6.283B 0.00
Reata Pharmaceuticals (RETA) United States $6.261B 0.00
Exelixis (EXEL) United States $5.946B 16.73
Ascendis Pharma (ASND) Denmark $5.773B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.687B 0.00
Repligen (RGEN) United States $5.190B 94.05
Bluebird Bio (BLUE) United States $4.964B 0.00
China Biologic Products (CBPO) China $4.584B 25.83
MorphoSys AG (MOR) Germany $4.207B 0.00
Immunomedics (IMMU) United States $3.587B 0.00
Mirati Therapeutics (MRTX) United States $3.523B 0.00
NeoGenomics (NEO) United States $3.444B 183.28
Adaptive Biotechnologies (ADPT) United States $3.339B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.306B 0.00
Blueprint Medicines (BPMC) United States $3.306B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.262B 0.00
MyoKardia (MYOK) United States $3.233B 0.00
Zai Lab (ZLAB) China $3.175B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.123B 0.00
Emergent Biosolutions (EBS) United States $3.000B 29.80
Genmab (GMAB) Denmark $2.959B 6.10
Halozyme Therapeutics (HALO) United States $2.882B 0.00
Alkermes (ALKS) Ireland $2.867B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.811B 0.00
Acceleron Pharma (XLRN) United States $2.800B 0.00
UniQure (QURE) Netherlands $2.698B 0.00
Epizyme (EPZM) United States $2.434B 0.00
Denali Therapeutics (DNLI) United States $2.391B 0.00
Amicus Therapeutics (FOLD) United States $2.362B 0.00
Arena Pharmaceuticals (ARNA) United States $2.295B 5.34
RA PHARMCTL INC (RARX) United States $2.209B 0.00
Myriad Genetics (MYGN) United States $2.142B 31.64
Principia Biopharma (PRNB) United States $1.974B 0.00
Fate Therapeutics (FATE) United States $1.878B 0.00
Insmed (INSM) United States $1.807B 0.00
Akcea Therapeutics (AKCA) United States $1.798B 0.00
Zymeworks (ZYME) Canada $1.776B 0.00
Arvinas (ARVN) United States $1.716B 0.00
REGENXBIO (RGNX) United States $1.661B 0.00
Alector (ALEC) United States $1.604B 0.00
Ligand Pharmaceuticals (LGND) United States $1.580B 30.39
Editas Medicine (EDIT) United States $1.486B 0.00
Intra-Cellular Therapies (ITCI) United States $1.378B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.352B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.339B 0.00
Coherus BioSciences (CHRS) United States $1.313B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.289B 0.00
Athenex (ATNX) United States $1.163B 0.00
Zealand Pharma (ZEAL) Denmark $1.161B 0.00
DBV Technologies S.A (DBVT) France $1.059B 0.00
Mesoblast (MESO) Australia $1.054B 0.00
Revance Therapeutics (RVNC) United States $1.007B 0.00
Codexis (CDXS) United States $1.002B 0.00
PHARMA MAR SA (PHMMF) Spain $0.965B 0.00
Sangamo Therapeutics (SGMO) United States $0.929B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.915B 0.00
Pharming Group (PHGUF) Netherlands $0.909B 0.00
Heska (HSKA) United States $0.853B 218.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.813B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.800B 6.73
Adverum Biotechnologies (ADVM) United States $0.752B 0.00
Cytokineticsorporated (CYTK) United States $0.748B 0.00
Vericel (VCEL) United States $0.748B 278.83
ANI Pharmaceuticals (ANIP) United States $0.745B 12.71
GENFIT S.A (GNFT) France $0.734B 0.00
Twist Bioscience (TWST) United States $0.725B 0.00
Retrophin (RTRX) United States $0.713B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.708B 0.00
Cellectis S.A (CLLS) France $0.704B 0.00
Sorrento Therapeutics (SRNE) United States $0.703B 0.00
Intellia Therapeutics (NTLA) United States $0.690B 0.00
NantKwest (NK) United States $0.666B 0.00
Anika Therapeutics (ANIK) United States $0.656B 21.28
Cara Therapeutics (CARA) United States $0.654B 0.00
UROGEN PHARMA (URGN) United States $0.648B 0.00
AC Immune SA (ACIU) Switzerland $0.625B 14.45
Kadmon Holdings (KDMN) United States $0.581B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.568B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.548B 0.00
Prothena (PRTA) Ireland $0.535B 0.00
Agenus (AGEN) United States $0.527B 0.00
BioDelivery Sciences (BDSI) United States $0.521B 0.00
Precision BioSciences (DTIL) United States $0.513B 0.00
Cel-Sci (CVM) United States $0.508B 0.00
Clovis Oncology (CLVS) United States $0.505B 0.00
Dynavax Technologies (DVAX) United States $0.481B 0.00
Bellus Health (BLU) Canada $0.477B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Arcus Biosciences (RCUS) United States $0.434B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.422B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.405B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.401B 0.00
AnaptysBio (ANAB) United States $0.401B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.397B 0.00
Merus (MRUS) Netherlands $0.396B 0.00
Avid Bioservices (CDMO) United States $0.383B 0.00
Mersana Therapeutics (MRSN) United States $0.379B 0.00
Kindred Biosciences (KIN) United States $0.378B 0.00
PDL BioPharma (PDLI) United States $0.372B 9.31
Lexicon Pharmaceuticals (LXRX) United States $0.366B 2.53
Gritstone Oncology (GRTS) United States $0.360B 0.00
Pfenex (PFNX) United States $0.358B 0.00
MannKind (MNKD) United States $0.351B 0.00
OSMOTICA PHARM (OSMT) United States $0.350B 0.00
POXEL SA FRANCE (PXXLF) France $0.350B 0.00
Cue Biopharma (CUE) United States $0.350B 0.00
CytomX Therapeutics (CTMX) United States $0.349B 0.00
Stemline Therapeutics (STML) United States $0.347B 0.00
Puma Biotechnology (PBYI) United States $0.344B 0.00
Syros Pharmaceuticals (SYRS) United States $0.338B 0.00
Compugen (CGEN) Israel $0.334B 0.00
Cellular Biomedicine (CBMG) United States $0.329B 0.00
Starpharma Holdings (SPHRY) Australia $0.305B 0.00
Albireo Pharma (ALBO) United States $0.300B 0.00
IVERIC Bio (ISEE) United States $0.281B 0.00
Geron (GERN) United States $0.280B 0.00
Kamada (KMDA) Israel $0.275B 8.05
Sutro Biopharma (STRO) United States $0.270B 0.00
ADMA Biologics Inc (ADMA) United States $0.269B 0.00
WAVE Life Sciences (WVE) Singapore $0.268B 0.00
Prometic Life Sciences (LMNL) Canada $0.261B 0.00
Biofrontera AG (BFRA) Germany $0.254B 0.00
ChromaDex (CDXC) United States $0.251B 0.00
Seres Therapeutics (MCRB) United States $0.246B 0.00
Novavax (NVAX) United States $0.246B 0.00
VBI Vaccines (VBIV) United States $0.230B 0.00
Exicure (XCUR) United States $0.226B 0.00
Affimed (AFMD) Germany $0.224B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.221B 0.00
Theratechnologies (THTX) Canada $0.219B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.215B 0.00
Five Prime Therapeutics (FPRX) United States $0.212B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.209B 0.00
Athersys (ATHX) United States $0.208B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.207B 0.00
Cerecor (CERC) United States $0.204B 0.00
XOMA (XOMA) United States $0.203B 0.00
Protagonist Therapeutics (PTGX) United States $0.202B 0.00
Aptinyx (APTX) United States $0.202B 0.00
Arbutus Biopharma (ABUS) Canada $0.194B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.191B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.190B 0.00
Fortress Biotech (FBIO) United States $0.187B 0.00
Spero Therapeutics (SPRO) United States $0.184B 0.00
Windtree Therapeutics (WINT) United States $0.181B 0.00
Alcobra (ARCT) United States $0.181B 0.00
TELA Bio (TELA) United States $0.179B 0.00
CorMedix Inc (CRMD) United States $0.171B 0.00
PHASEBIO PHARMA (PHAS) United States $0.166B 0.00
Strongbridge Biopharma (SBBP) United States $0.165B 4.41
Palatin Technologies (PTN) United States $0.163B 4.45
ARAVIVE, INC (ARAV) United States $0.160B 0.00
Selecta Biosciences (SELB) United States $0.154B 0.00
Applied Genetic Technologies (AGTC) United States $0.152B 0.00
Dyadic (DYAI) United States $0.151B 0.00
Menlo Therapeutics (MNLO) United States $0.146B 0.00
Abeona Therapeutics (ABEO) United States $0.144B 0.00
Verastem (VSTM) United States $0.144B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.142B 7.31
VTv Therapeutics (VTVT) United States $0.137B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Liquidia Technologies (LQDA) United States $0.133B 0.00
Aduro Biotech (ADRO) United States $0.127B 0.00
Northwest Biotherapeutics (NWBO) United States $0.124B 0.00
Clearside Biomedical (CLSD) United States $0.122B 0.00
Enzo Biochem (ENZ) United States $0.121B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.121B 0.00
Arsanis (XFOR) United States $0.119B 0.00
OvaScience (MLND) United States $0.114B 0.00
Acorda Therapeutics (ACOR) United States $0.114B 0.00
Happiness Biotech Group (HAPP) China $0.113B 0.00
Celyad SA (CYAD) Belgium $0.111B 0.00
Antibe Therapeutics (ATBPF) Canada $0.108B 0.00
SESEN BIO, INC (SESN) United States $0.097B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.097B 0.00
Proteostasis Therapeutics (PTI) United States $0.096B 0.00
AIT Therapeutics (XAIR) United States $0.089B 0.00
Synlogic (SYBX) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Trevena (TRVN) United States $0.084B 0.00
Catalyst Biosciences (CBIO) United States $0.082B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.082B 0.00
Emmaus Life Sciences (EMMA) United States $0.081B 0.00
Prima BioMed (IMMP) Australia $0.078B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.077B 0.00
Orgenesis (ORGS) United States $0.076B 4.93
Vaccinex (VCNX) United States $0.076B 0.00
Checkpoint Therapeutics (CKPT) United States $0.075B 0.00
NewLink Genetics (NLNK) United States $0.075B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.063B 0.00
Soligenix (SNGX) United States $0.062B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
Protalix BioTherapeutics (PLX) Israel $0.056B 0.00
Idera Pharmaceuticals (IDRA) United States $0.055B 0.00
Curis (CRIS) United States $0.055B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
AquaBounty Technologies (AQB) United States $0.049B 0.00
DiaMedica Therapeutics (DMAC) United States $0.048B 0.00
Organovo Holdings (ONVO) United States $0.046B 0.00
Evogene (EVGN) Israel $0.044B 0.00
CollPlant Holdings (CLGN) Israel $0.041B 0.00
Celldex Therapeutics (CLDX) United States $0.038B 0.00
Alimera Sciences (ALIM) United States $0.037B 0.00
BioCardia (BCDA) United States $0.036B 0.00
Celsion (CLSN) United States $0.036B 0.00
Unum Therapeutics (UMRX) United States $0.035B 0.00
Entera Bio (ENTX) Israel $0.035B 0.00
Pulmatrix (PULM) United States $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.032B 0.00
Bionano Genomics (BNGO) United States $0.031B 0.00
Oncobiologics (OTLK) United States $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
AmpliPhi Biosciences (ARMP) United States $0.029B 0.00
VIVUS (VVUS) United States $0.028B 0.00
Novogen (KZIA) Australia $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.026B 0.00
Stellar Biotechnologies (EDSA) Canada $0.025B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Titan Pharmaceuticals (TTNP) United States $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Advaxis (ADXS) United States $0.017B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
TrovaGene (TROV) United States $0.014B 0.00
TRACON Pharmaceuticals (TCON) United States $0.014B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
Cesca Therapeutics (THMO) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
IBio (IBIO) United States $0.010B 0.00
BioPharmX (BPMX) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.005B 0.00